The Study on Reliability and Validity of Korean Version of the Barratt Impulsiveness Scale-11-Revised in Nonclinical Adult Subjects.
10.4306/jknpa.2012.51.6.378
- Author:
So Ra LEE
1
;
Won Hye LEE
;
Jeong Soo PARK
;
Seol Min KIM
;
Jong Woo KIM
;
Je Hyun SHIM
Author Information
1. Department of Psychiatry, VHS Medical Center, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Korean version of Barratt Impulsiveness Scale-11-Revised;
Reliability;
Validity;
Factor analysis
- MeSH:
Adult;
Factor Analysis, Statistical;
Hostility;
Humans;
Reproducibility of Results
- From:Journal of Korean Neuropsychiatric Association
2012;51(6):378-386
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVES: This study was conducted in order to determine the validity and reliability of the Korean version of the Barratt Impulsiveness Scale-11-Revised (K-BIS-11-R) in Nonclinical Adult Subjects. METHODS: The K-BIS-11-R was tested in non-clinical (n=270) native Korean-speakers. Internal consistency reliability was calculated using Cronbach's alpha and test-retest reliability was measured using Pearson correlations. To see external validity, we performed confirmatory factor analysis for determination of whether the three-factor model, proposed by the previous report, fit the data. RESULTS: According to the results, the K-BIS-11-R had an acceptable test-retest reliability and internal consistency reliability. In addition, the K-BIS-11-R total score and second-order subscale score showed significant correlation with Conners' Adult attention deficit/hyperactivity disorder Rating Scale-Korean and Buss & Durkee Hostility Inventory. In addition, no significant difference was observed between the K-BIS-11-R total score and demographic variables. Thus, the K-BIS-11-R total score was transformed to standard score. CONCLUSION: K-BIS-11-R is a reliable and valid measure and has possible utility for assessment of impulsiveness in nonclinical adult subjects. Further research is needed in order to determine the cutoff score for administration of K-BIS-11-R to clinical adult subjects.